Qinetiq cuts guidance amid near-term pressures, shares slide 07:47 , Graeme Evans. FTSE 250-listed defence and security firm ...

This FTSE 100 stock hasn't exactly set our writer's portfolio on fire during the time he's owned it. But Paul Summers remains ...

Harvey Jones crunches the numbers to show how it's possible to build a long-term second income by investing in a spread of ...

AstraZeneca has struck a deal to acquire biotechnology EsoBiotec for up to $1bn, as the London-listed pharmaceuticals group expands its investments in cell therapies for treating cancer.

The Shell share price hasn’t moved much in the last 12 months, but analyst forecasts predict that could change significantly ...